Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients. Here's what to know. ⤵️
| Do you know someone who would like to receive The Advocate newsletter? Share it with them! |
| Keep up with the latest LGBTQ+ news -- from politics to entertainment to opinions from queer voices. |
The Advocate is part of equalpride, a proudly LGBTQ-owned and operated media company that serves as a leading voice on equality with LGBTQ, women and people of color.
Follow us
Copyright © 2024 equalpride. All rights reserved.
PO Box 241579, Los Angeles, CA 90024
